A multicenter Phase II study of the intr
โ
Zale P. Bernstein; Asher Chanan-Khan; Kena C. Miller; Donald W. Northfelt; Gabri
๐
Article
๐
2002
๐
John Wiley and Sons
๐
English
โ 97 KB
## Background: A multicenter trial was conducted to determine the efficacy and toxicity of escalating dosages of liposomal tretinoin (all-trans-retinoic acid) administered once or three times weekly in patients with acquired immunodeficiency syndrome (aids)-associated kaposi sarcoma. ## Methods: